For his work in Latin America, he was awarded the George Rosenkranz Prize for Health Care Research in Developing Countries in 2012. He later became Research Associate of the Genetics Department at Stanford University until 2014.

Carlos Bustamante’s group at Cornell University and Stanford University School of Medicine. Moreno was a postdoctoral fellow from 2009 to 2012 in Dr. in Evolutionary Genetics in Barcelona (Pompeu Fabra University, 2009), where he was trained in human population genetics working on the analysis of genetic variation in candidate genes under positive selection on the human lineage. He is a medical doctor by training (University of Guadalajara, 2002) and pursued a Ph.D. National Laboratory of Genomics for Biodiversity (LANGEBIO), MexicoĪndrés Moreno-Estrada is a Mexican population geneticist interested in human genetic diversity and its implications in population history and medical genomics. Principal Investigator, Human Evolutionary Genomics Lab Medical genomics in underrepresented populations from Latin America to the Pacific He is a 2016 Senior TED Fellow and a 2016 WIRED Innovation Fellow and has been featured in several media outlets, including Forbes, Bloomberg, Wall Street Journal, New York Times, Washington Post, BBC, and TIME Magazine. Lin earned his MD and PhD from Johns Hopkins School of Medicine and a Master of Health Science from the Johns Hopkins Bloomberg School of Public Health, creating genome-wide maps of breast, colorectal, pancreatic, glioblastoma, medulloblastoma, and melanoma cancers, as well as mapping the genome of an anaerobic bacteria that is used as anti-tumor therapy. Lin led the ClinOmics program at the National Cancer Institute (NIH/NCI) and was a research instructor at Washington University in St. Prior to Freenome, he was the Chief Scientific Officer, Oncology at Natera where he led the development of new diagnostic technologies for cancer.īefore his career in private industry, Dr. Lin is also the Chief Scientific Officer at Freenome, working on early diagnostic of cancers. Jimmy Lin, M.D., Ph.D., MHS is the Founder and Chief Executive Officer of Rare Genomics (RG) Institute, an international non-profit founded in 2011 to enable any community to leverage cutting-edge biotechnology to advance understanding of rare diseases.

Iftikhar kullo md